3/11/2022Recent Executive Moves

3/11/2022Drug R&D and Product Registration News Digest March 2022 (2)

3/10/2022AmCham Survey, U.S. Firms Less Optimistic About Making New Investments...

3/10/2022SEC Sets Clock for Delisting Chinese Companies Over US Audit Demand (U...

3/10/2022Zai Lab Revenue Triples, As It Struggles to Break Cycle of Mounting Lo...

3/9/2022Snapshot of MNC Pharma's China Performance in 2021 (Updated)

3/9/2022Lonza Expands API Development and Manufacturing Laboratories in Nansha

3/9/2022Hanmi to Launch High Blood Pressure Drug Amosartan in China

3/9/2022China Meheco Inks Deal to Market Pfizer's Covid Pill Paxlovid in China

3/7/2022Altamira and Nuance Enter Licensing and Distribution Deal for Bentrio ...

3/7/2022Hutchmed Gets $15M from AstraZeneca as Part of Orpathys Drug Program i...

3/7/2022J&J Reportedly in Talks for Biotech Deals in China

3/7/2022NHSA Releases Its 2021 Healthcare Security Sector Development Statisti...

3/7/2022NHC Establishes the Pharmacy Management and Drug Therapy Committee

3/7/2022Central Government Report Emphasizes on Nine Healthcare Reform Measure...

3/4/2022Drug R&D and Product Registration News Digest March 2022 (1)

3/4/2022Recent Executive Moves

3/3/2022China Conditionally Approves First Recombinant Protein COVID-19 Vaccin...

3/3/2022WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at ...

3/3/2022Aquestive and Haisco Enter Licensing and Supply Deal for Riluzole Oral...

3/3/2022Eutilex Signs MOU with OBiO for Developing Cell Therapies in China

3/3/2022Lesson from China's National Negotiation of Drug Prices in 2021 (NLR)

3/3/2022Domestic Chinese Checkpoint Inhibitors: A Big Threat to Western Pharm...

3/2/2022FDA OKs J&J and Legend's BCMA CAR-T, Setting Stage for Showdown with B...

3/2/2022Adagene and Sanofi Enter SAFEbody Multi-Target Collaboration for Nove...

3/2/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (56...

3/2/2022Gene Therapy Startup Grit Science Raises CNY Hundreds of Millions

3/2/2022Tasly Reportedly Eyeing to Terminate License Pact with Sutro Biopharma

3/2/2022The New Chinese Physicians Law Contains Provisions on Clinical Guideli...

3/1/2022Financial-related Company News Digest

Page:163/790 Total number of articles:23693: [First][<<] [161] [162] [163] [164] [165] [>>] [End]